Cargando…
The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial
In March 2020, the World Health Organization (WHO) announced a global pandemic of coronavirus disease 2019 (COVID-19) that presented mainly as an acute infection of the lower respiratory tract (pneumonia), with multiple long-term consequences, including lung fibrosis. The aim of this study was to ev...
Autores principales: | Karolak, Igor, Hrynkiewicz, Rafał, Niedźwiedzka-Rystwej, Paulina, Lechowicz, Kacper, Sieńko, Jerzy, Szylińska, Aleksandra, Dabrowski, Wojciech, Kotfis, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532011/ https://www.ncbi.nlm.nih.gov/pubmed/37762549 http://dx.doi.org/10.3390/ijms241814247 |
Ejemplares similares
-
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial
por: Kotfis, Katarzyna, et al.
Publicado: (2022) -
Etiology of viral induced acute liver failure and defensins as potential therapeutic agents in ALF treatment
por: Hrynkiewicz, Rafał, et al.
Publicado: (2023) -
Myeloperoxidase and Lysozymes as a Pivotal Hallmark of Immunity Status in Rabbits
por: Hrynkiewicz, Rafał, et al.
Publicado: (2020) -
Acute and Chronic Pain Learning and Teaching in Medical School—An Observational Cross-Sectional Study Regarding Preparation and Self-Confidence of Clinical and Pre-Clinical Medical Students
por: Lechowicz, Kacper, et al.
Publicado: (2019) -
COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
por: Kotfis, Katarzyna, et al.
Publicado: (2021)